trans-4-Methoxycyclohexanamine Hydrochloride - CAS 61367-41-7
Catalog: |
BB056414 |
Product Name: |
trans-4-Methoxycyclohexanamine Hydrochloride |
CAS: |
61367-41-7 |
Synonyms: |
(trans-4-Methoxycyclohexyl)amine Hydrochloride; trans-4-Methoxycyclohexanamine Monohydrochloride |
IUPAC Name: | 4-methoxycyclohexan-1-aminehydrochloride |
Description: | trans-4-Methoxycyclohexanamine Hydrochloride is used in the synthesis of analogs of N- (2- chloroethyl) - N'- (trans- 4- methylcyclohexyl) - N- nitrosourea as anticancer agents. |
Molecular Weight: | 165.66 |
Molecular Formula: | C7H16ClNO |
Canonical SMILES: | COC1CCC(CC1)N.Cl |
InChI: | InChI=1S/C7H15NO.ClH/c1-9-7-4-2-6(8)3-5-7/h6-7H,2-5,8H2,1H31H |
InChI Key: | DUVKXMNYICFZCS-UHFFFAOYSA-N |
Melting Point: | 199-200°C |
Solubility: | DMSO (Slightly), Methanol (Slightly) |
Appearance: | White Solid |
Storage: | Hygroscopic, Refrigerator, under inert atmosphere |
References: | Johnston, T., et al.:J. Med. Chem., 20, 279 (1977). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112979646-A | Imidazopyridine derivative | 20210308 |
CN-112979646-B | Imidazopyridine derivative | 20210308 |
WO-2021085653-A1 | 4-aminobut-2-enamide derivatives and salts thereof | 20191031 |
TW-202128632-A | 4-aminobut-2-enamide derivatives and salts thereof | 20191031 |
WO-2019185631-A1 | 4â€"(1hâ€" imidazolâ€" 5â€" yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors | 20180329 |
AU-2019246220-A1 | 4â€"(1hâ€" imidazolâ€" 5â€" yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors | 20180329 |
AU-2019246220-B2 | 4â€"(1hâ€" imidazolâ€" 5â€" yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors | 20180329 |
CA-3085967-A1 | 4-(1h-imidazol-5-yl)-1h-pyrrolo[2,3-b]pyridines for use in the treatment of leukaemias, lymphomas and solid tumors | 20180329 |
CN-111936496-A | Use of 4- (1H-imidazol-5-yl) -1H-pyrrolo [2,3-B ] pyridine for the treatment of leukemias, lymphomas and solid tumors | 20180329 |
KR-20200116137-A | 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine for use in the treatment of leukemia, lymphoma and solid tumors | 20180329 |
Complexity: | 77 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 165.0920418 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 165.0920418 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 35.2Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[30360-19-1]
N,N'-Diethyl-N''-isopropyl-1,3,5-triazine-2,4,6-triamine
-
[104517-96-6]
Ioversol related compound B
-
[169689-05-8]
1S,2S-DHAC-Phenyl Trost Ligand
-
[119-24-4]
Folic Acid EP Impurity D (Methotrexate EP Impurity D)
-
[1118-71-4]
2,2,6,6-Tetramethyl-3,5-heptanedione
-
[24292-52-2]
Hesperidin methyl chalcone
INDUSTRY LEADERS TRUST OUR PRODUCTS